Alok Khorana

Feb 1, 2024 | ccjm.org | Heloni Dave |Alok Khorana

KEY POINTS Patients with cancer are at a much higher risk of developing VTE than the general population. Low-molecular-weight heparin or direct oral anticoagulants are preferred over vitamin K antagonists. Direct oral anticoagulants are generally preferred, but caution is needed in patients at risk of bleeding.

Dec 15, 2023 | cancernetwork.com | Suneel Kamath |Joanna Roopkumar |Ying Ni |Minqian Shen |Pablo G. Bejarano |Daniela Allende | +9 more

December 15, 2023OncologyONCOLOGY Vol 37, Issue 12Pages: 488-495Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer. ABSTRACTIntroduction: Exceptional response to therapy is rare in patients with advanced pancreatic cancer. This study explored potential genomic differences between typical and exceptional responses that could confer more favorable biology.

Dec 15, 2023 | cancernetwork.com | Suneel Kamath |Joanna Roopkumar |Ying Ni |Minqian Shen |Pablo G. Bejarano |Daniela Allende | +9 more

December 15, 2023OncologyONCOLOGY Vol 37, Issue 12Pages: 488-495Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer. ABSTRACTIntroduction: Exceptional response to therapy is rare in patients with advanced pancreatic cancer. This study explored potential genomic differences between typical and exceptional responses that could confer more favorable biology.

Dec 15, 2023 | cancernetwork.com | Suneel Kamath |Joanna Roopkumar |Ying Ni |Minqian Shen |Pablo G. Bejarano |Daniela Allende | +9 more

December 15, 2023OncologyONCOLOGY Vol 37, Issue 12Pages: 488-495Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer. ABSTRACTIntroduction: Exceptional response to therapy is rare in patients with advanced pancreatic cancer. This study explored potential genomic differences between typical and exceptional responses that could confer more favorable biology.

Nov 1, 2023 | mainereview.com | Alok Khorana

The harsh overhead tube lights flickered, fading almost to darkness then sparkling back to life, as a bone-tired Vivek entered the inpatient ward.  On paper, Vivek was merely a trainee physician in his first year of residency. What this meant in the real world, however, was that he was one of only two in-house doctors managing forty-odd patients at the government hospital.